686 related articles for article (PubMed ID: 23459929)
1. The role of markers of inflammation in traumatic brain injury.
Woodcock T; Morganti-Kossmann MC
Front Neurol; 2013; 4():18. PubMed ID: 23459929
[TBL] [Abstract][Full Text] [Related]
2. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury.
Ziebell JM; Morganti-Kossmann MC
Neurotherapeutics; 2010 Jan; 7(1):22-30. PubMed ID: 20129494
[TBL] [Abstract][Full Text] [Related]
3. Emerging Roles for the Immune System in Traumatic Brain Injury.
McKee CA; Lukens JR
Front Immunol; 2016; 7():556. PubMed ID: 27994591
[TBL] [Abstract][Full Text] [Related]
4. Connecting cellular mechanisms and extracellular vesicle cargo in traumatic brain injury.
Ollen-Bittle N; Roseborough AD; Wang W; Wu JD; Whitehead SN
Neural Regen Res; 2024 Oct; 19(10):2119-2131. PubMed ID: 38488547
[TBL] [Abstract][Full Text] [Related]
5. Traumatic inflammatory response: pathophysiological role and clinical value of cytokines.
Li R; Ye JJ; Gan L; Zhang M; Sun D; Li Y; Wang T; Chang P
Eur J Trauma Emerg Surg; 2023 Dec; ():. PubMed ID: 38151578
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and neuroprotection in traumatic brain injury.
Corps KN; Roth TL; McGavern DB
JAMA Neurol; 2015 Mar; 72(3):355-62. PubMed ID: 25599342
[TBL] [Abstract][Full Text] [Related]
7. Microglia activation as a biomarker for traumatic brain injury.
Hernandez-Ontiveros DG; Tajiri N; Acosta S; Giunta B; Tan J; Borlongan CV
Front Neurol; 2013; 4():30. PubMed ID: 23531681
[TBL] [Abstract][Full Text] [Related]
8. The contribution of astrocytes and microglia to traumatic brain injury.
Karve IP; Taylor JM; Crack PJ
Br J Pharmacol; 2016 Feb; 173(4):692-702. PubMed ID: 25752446
[TBL] [Abstract][Full Text] [Related]
9. Chronic Inflammation After Severe Traumatic Brain Injury: Characterization and Associations With Outcome at 6 and 12 Months Postinjury.
Kumar RG; Boles JA; Wagner AK
J Head Trauma Rehabil; 2015; 30(6):369-81. PubMed ID: 24901329
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines.
Gyoneva S; Ransohoff RM
Trends Pharmacol Sci; 2015 Jul; 36(7):471-80. PubMed ID: 25979813
[TBL] [Abstract][Full Text] [Related]
11. Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities.
Lozano D; Gonzales-Portillo GS; Acosta S; de la Pena I; Tajiri N; Kaneko Y; Borlongan CV
Neuropsychiatr Dis Treat; 2015; 11():97-106. PubMed ID: 25657582
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury.
Knoblach SM; Faden AI
Exp Neurol; 1998 Sep; 153(1):143-51. PubMed ID: 9743576
[TBL] [Abstract][Full Text] [Related]
13. Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury.
Abdul-Muneer PM; Chandra N; Haorah J
Mol Neurobiol; 2015; 51(3):966-79. PubMed ID: 24865512
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury.
Katz PS; Sulzer JK; Impastato RA; Teng SX; Rogers EK; Molina PE
J Neurotrauma; 2015 Mar; 32(5):297-306. PubMed ID: 25166905
[TBL] [Abstract][Full Text] [Related]
15. Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury.
Yan EB; Satgunaseelan L; Paul E; Bye N; Nguyen P; Agyapomaa D; Kossmann T; Rosenfeld JV; Morganti-Kossmann MC
J Neurotrauma; 2014 Apr; 31(7):618-29. PubMed ID: 24279428
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor in traumatic brain injury: effects of genetic deletion of p55 or p75 receptor.
Longhi L; Perego C; Ortolano F; Aresi S; Fumagalli S; Zanier ER; Stocchetti N; De Simoni MG
J Cereb Blood Flow Metab; 2013 Aug; 33(8):1182-9. PubMed ID: 23611870
[TBL] [Abstract][Full Text] [Related]
17. Clinical evidence of inflammation driving secondary brain injury: a systematic review.
Hinson HE; Rowell S; Schreiber M
J Trauma Acute Care Surg; 2015 Jan; 78(1):184-91. PubMed ID: 25539220
[TBL] [Abstract][Full Text] [Related]
18. Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date.
Tuttolomondo A; Pecoraro R; Pinto A
Drug Des Devel Ther; 2014; 8():2221-38. PubMed ID: 25422582
[TBL] [Abstract][Full Text] [Related]
19. Transcranial amelioration of inflammation and cell death after brain injury.
Roth TL; Nayak D; Atanasijevic T; Koretsky AP; Latour LL; McGavern DB
Nature; 2014 Jan; 505(7482):223-8. PubMed ID: 24317693
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 6 mediates neuroinflammation and motor coordination deficits after mild traumatic brain injury and brief hypoxia in mice.
Yang SH; Gangidine M; Pritts TA; Goodman MD; Lentsch AB
Shock; 2013 Dec; 40(6):471-5. PubMed ID: 24088994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
